{"id":"W4212782745","doi":"10.1200/jco.2022.40.6_suppl.318","title":"CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Calgary","funders":"Ipsen","keywords":"Medicine; Cabozantinib; Ipilimumab; Nivolumab; Internal medicine; Renal cell carcinoma; Oncology; Hazard ratio; Cohort; Clear cell renal cell carcinoma; Cancer; Immunotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001279195,0.000260682,0.0007634251,0.0006686571,0.0001788336,0.0007362223,0.0006575941,0.0004096708,0.001715937],"category_scores_gemma":[0.002264402,0.0001193385,0.001017376,0.001608239,0.0001925821,0.0004513042,0.0005814559,0.0004655287,0.0003516616],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008153921,"about_ca_system_score_gemma":0.0007593394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006298014,"about_ca_topic_score_gemma":0.01463804,"domain_scores_codex":[0.9991068,0.0002373289,0.0001427572,0.0002191911,0.000197829,0.00009604595],"domain_scores_gemma":[0.9973696,0.0004911707,0.001518812,0.0001434087,0.0002314,0.0002456306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01774164,0.0002360001,0.9467237,0.0009616392,0.001773536,0.0001066754,0.00008391777,0.001038216,0.0006560355,0.0001721799,0.01092775,0.01957873],"study_design_scores_gemma":[0.002793432,0.001430281,0.9800522,0.0001996117,0.001336444,0.000486413,0.0001558414,0.00230015,0.0005482266,0.0001733486,0.01049388,0.00003003357],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9114457,0.005226616,0.0002054405,0.0004196957,0.00002349925,0.0001516418,0.08063424,0.00004289159,0.001850315],"genre_scores_gemma":[0.917279,0.001074594,0.0003438512,0.0003353672,0.00004050585,0.0001162754,0.08035019,0.000011306,0.0004490264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006298014,"threshold_uncertainty_score":0.0125227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05525645971141906,"score_gpt":0.3596072690592794,"score_spread":0.3043508093478603,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}